A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes

J Arredondo1, V T Nguyen, A I Chernyavsky

  • 1Department of Dermatology, School of Medicine, University of California, Davis 95817, USA.

Insights

Nicotine in tobacco alters oral keratinocyte nicotinic acetylcholine receptors (nAChRs), affecting cell cycle and differentiation. These changes, observed in vitro and in vivo, contribute to tobacco-related oral tissue damage.

Area of Science:

  • Cell Biology
  • Toxicology
  • Dermatology

Background:

  • Tobacco use, including smoking and smokeless forms, is a significant cause of oral tissue morbidity.
  • Oral keratinocytes (OKC) possess nicotinic acetylcholine receptors (nAChRs) that interact with nicotine (Nic).

Purpose of the Study:

  • To investigate the mechanism of nicotine-induced toxicity on oral keratinocytes.
  • To elucidate how nicotine affects nAChR structure, function, and gene expression in OKC.
  • To determine the in vivo relevance of these findings in oral tissues.

Main Methods:

  • Exposure of human OKC and rodent oral tissues to nicotine or environmental cigarette smoke.
  • Analysis of nAChR subunit expression using RT-PCR and immunoblotting.
  • Assessment of cell cycle and differentiation markers (e.g., Ki-67, p53, filaggrin) via molecular and immunofluorescence techniques.
  • Pharmacological blockade of nAChRs using mecamylamine.

Main Results:

  • Nicotine exposure altered nAChR ligand-binding kinetics and increased mRNA/protein levels of specific nAChR subunits (alpha3, alpha5, alpha7, beta2, beta4).
  • Nicotine modulated the expression of cell cycle regulators (Ki-67, PCNA, p21, cyclin D1, p53) and differentiation markers (filaggrin, loricrin, cytokeratins).
  • These nicotine-induced changes were prevented by the nAChR antagonist mecamylamine, confirming receptor mediation.
  • Similar alterations in nAChRs and related genes were observed in rodent oral tissues exposed to cigarette smoke or nicotine.

Conclusions:

  • Nicotine-induced structural and functional changes in keratinocyte nAChRs contribute to tobacco-related pathobiological effects in oral tissues.
  • These alterations impact the regulation of cell cycle and differentiation pathways.
  • The findings highlight a key mechanism underlying oral tissue damage from tobacco products.

Related Concept Videos

Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...